Corcept Therapeutics, Inc. (CORT)
34.73
-0.66
(-1.86%)
USD |
NASDAQ |
Jan 16, 16:00
34.28
-0.45
(-1.30%)
Pre-Market: 09:13
Corcept Therapeutics EPS Diluted (Quarterly): 0.1621 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | -0.9442 |
| Johnson & Johnson | 2.121 |
| United Therapeutics Corp. | 7.161 |
| Ultragenyx Pharmaceutical, Inc. | -1.808 |
| Amicus Therapeutics, Inc. | 0.0558 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.36M |
| Revenue (Quarterly) | 207.64M |
| Total Expenses (Quarterly) | 188.28M |
| Enterprise Value | 3.238B |
| Gross Profit Margin (Quarterly) | 97.79% |
| Profit Margin (Quarterly) | 9.32% |
| Earnings Yield | 2.52% |
| Operating Earnings Yield | 1.58% |
| Normalized Earnings Yield | 2.52 |